Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Management of Covid-19 Patients During Home Isolation

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04368923
Recruitment Status : Active, not recruiting
First Posted : April 30, 2020
Last Update Posted : June 23, 2020
Sponsor:
Information provided by (Responsible Party):
Mahmoud Sedky, Cairo University

Brief Summary:
This study will be concerned with managing patients of Covid-19 while being home isolated.

Condition or disease Intervention/treatment Phase
Covid 19 Device: Oxygen Therapy Procedure: Physical Therapy Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 60 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Management of Covid-19 Patients During Home Isolation
Actual Study Start Date : March 15, 2020
Estimated Primary Completion Date : June 21, 2020
Estimated Study Completion Date : June 23, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Oxygen Therapy

Arm Intervention/treatment
Experimental: Oxygen Therapy Group Device: Oxygen Therapy
Patients receive oxygen therapy

Experimental: Physical Therapy Group Procedure: Physical Therapy
Patients receive physical therapy




Primary Outcome Measures :
  1. Arterial Blood Gases (ABG): Partial Pressure of Oxygen and Carbon Dioxide [ Time Frame: 48 hours ]
  2. Arterial Blood Gases (ABG): Acidity Potential Hydrogen (pH) [ Time Frame: 48 hours ]

Secondary Outcome Measures :
  1. Vital Signs (Temprature) [ Time Frame: 24 hours ]
  2. Vital Signs (Respiratory Rate) [ Time Frame: 24 hours ]
  3. Vital Signs (Oxygen Saturation) [ Time Frame: 24 hours ]
  4. Vital Signs (Heart Rate) [ Time Frame: 24 hours ]
  5. Vital Signs (Blood Pressure) [ Time Frame: 24 hours ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   21 Years to 40 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with Covid-19
  • American Society of Anesthesiologists (ASA) class I
  • >= 21 years old
  • <= 40 years old

Exclusion Criteria:

  • ASA class II, class III or class IV

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04368923


Locations
Layout table for location information
Egypt
M. Sedky
Cairo, Egypt
Sponsors and Collaborators
Cairo University
Layout table for additonal information
Responsible Party: Mahmoud Sedky, Principal Investigator, Cairo University
ClinicalTrials.gov Identifier: NCT04368923    
Other Study ID Numbers: REC/012-2020
First Posted: April 30, 2020    Key Record Dates
Last Update Posted: June 23, 2020
Last Verified: June 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: No